| Metric | FY2021 | FY2020 |
|---|---|---|
| Total revenues | $5.7M+794.6% | $632K |
| Cost of product sales | $4.3M+64.1% | $2.6M |
| General and administrative | $11.7M+65.0% | $7.1M |
| Research and development | $11.7M+253.3% | $3.3M |
| Sales and marketing | $543K+76.2% | $308K |
| Impairment loss on construction in progress | — | $1.4M |
| Total expenses | $28.3M+92.0% | $14.7M |
| LOSS FROM OPERATIONS | -$22.7M-90.5% | -$11.9M |
| (Gain) loss on change in fair value of warrant liabilities | -$4.7M-156.8% | $8.3M |
| Gain on loan extinguishment | — | -$451K |
| Interest (income) expense, net | -$43K-188.9% | $48K |
| Other income, net | -$5K+97.9% | -$256K |
| Total other (income) expense, net | -$4.8M-162.4% | $7.7M |
| LOSS BEFORE PROVISION FOR INCOME TAXES | -$17.9M+8.5% | -$19.5M |
| PROVISION FOR INCOME TAXES | — | $5K |
| NET LOSS | -$17.9M+8.4% | -$19.5M |
| Net loss per common share, basic and diluted | -$0.61+45.5% | -$1.12 |
| Weighted—average number of shares outstanding, basic and diluted | 29.3M+68.3% | 17.4M |
| Net Product Sales [Member] | ||
| License Revenue [Member] | ||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.